Manufacturer:
Accord BioPharma
Route of Administration:
Intravenous, Subcutaneous
Site of Care:
Outpatient
Website:
Enrollment Forms:
Synergen Prescription Form
Approved Indication:
- treatment of adults and pediatric patients 6 years and older with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy
- treatment of active psoriatic arthritis in adults and pediatric patients 6 years and older
- treatment of moderately-to-severely active Crohn’s disease in adults
- treatment of moderately-to-severely active ulcerative colitis in adults
Conditions:
- Crohn’s Disease
- Plaque Psoriasis
- Psoriatic Arthritis
- Ulcerative Colitis
Therapeutic Area:
- Dermatology
- Gastroenterology
- Rheumatology